What is a stock summary page? Click here for an overview.
Business Description
Bionomics Ltd
NAICS : 541714
SIC : 2834
ISIN : AU000000BNO5
Description
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.73 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -12.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -18.2 | |||||
| 3-Year EPS without NRI Growth Rate | 1.5 | |||||
| 3-Year FCF Growth Rate | -4 | |||||
| 3-Year Book Growth Rate | 36 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -55.17 | |||||
| 12-1 Month Momentum % | -74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.06 | |||||
| Quick Ratio | 2.06 | |||||
| Cash Ratio | 2.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 41.8 | |||||
| Shareholder Yield % | 2.81 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1050.53 | |||||
| Net Margin % | -414.48 | |||||
| FCF Margin % | -1131.81 | |||||
| ROE % | -16.14 | |||||
| ROA % | -11.55 | |||||
| ROIC % | -44.56 | |||||
| 3-Year ROIIC % | 292.25 | |||||
| ROC (Joel Greenblatt) % | -3262.3 | |||||
| ROCE % | -33.3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.14 | |||||
| PB Ratio | 0.61 | |||||
| EV-to-EBIT | -1.89 | |||||
| EV-to-Forward-EBIT | -0.09 | |||||
| EV-to-EBITDA | -1.98 | |||||
| EV-to-Forward-EBITDA | -0.06 | |||||
| EV-to-Revenue | 19.83 | |||||
| EV-to-Forward-Revenue | 0.51 | |||||
| EV-to-FCF | -1.69 | |||||
| Earnings Yield (Greenblatt) % | -52.91 | |||||
| FCF Yield % | -45.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bionomics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 1.047 | ||
| EPS (TTM) (A$) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.4 | ||
| 3-Year Sortino Ratio | -0.79 | ||
| Volatility % | 55.46 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (A$) | 0.001357 | ||
| 20-Day SMA (A$) | - | ||
| 12-1 Month Momentum % | -74 | ||
| 52-Week Range (A$) | 0.009 - 0.074 | ||
| Shares Outstanding (Mil) | 1,468.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bionomics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bionomics Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bionomics Ltd Frequently Asked Questions
What is Bionomics Ltd(ASX:BNO)'s stock price today?
The current price of ASX:BNO is A$0.01. The 52 week high of ASX:BNO is A$0.07 and 52 week low is A$0.01.
When is next earnings date of Bionomics Ltd(ASX:BNO)?
The next earnings date of Bionomics Ltd(ASX:BNO) is .
Does Bionomics Ltd(ASX:BNO) pay dividends? If so, how much?
Bionomics Ltd(ASX:BNO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers